Clinical Evaluation of EUS-FNA on Diagnosis of Pancreatic Cystic Lesions----A Multiple Center,Prospective Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pancreatic Cyst
- Sponsor
- Xiaoyin Zhang
- Enrollment
- 160
- Locations
- 1
- Primary Endpoint
- Rate of change of diagnosis
- Last Updated
- 12 years ago
Overview
Brief Summary
It is still controversial about the necessity of endoscopy ultrasound guide fine needle aspiration (EUS-FNA) on diagnosis of pancreatic cystic lesions(PCL).The aim of this study is to find the influence of EUS-FNA on diagnosis and suggestions of EUS specialists.
Detailed Description
First, the investigators will send only EUS images of patients with PCL to diagnosis committee that is consisted with 8 EUS specialists from different countries.The diagnosis will be collected. Then the investigators send the results of EUS-FNA. The diagnosis and suggestions will be collected again. The investigators will calculate how much diagnosis has been changed because of results of EUS-FNA. The investigators will also follow up these patients for 5 years at least to find if these patients benefit from EUS-FNA and complications such as needle tract seeding metastases.
Investigators
Xiaoyin Zhang
Associate professor
Air Force Military Medical University, China
Eligibility Criteria
Inclusion Criteria
- •Adults with ages from 18-80 years old.
- •The patients with pancreatic cystic lesions, which diameter of cystic lesion more than 2cm.
- •Sign the informed consent voluntarily. -
Exclusion Criteria
- •The patient can't accept the endoscopic procedure.
- •The patient has blood coagulation dysfunction.
- •The patient has mental disorders.
- •The patient has mild or severe cardiorespiratory insufficiency.
- •The patient has hypertension and can't be controlled to safe level.
- •Patients with alcohol dependence.
- •Pregnant and lactating women.
- •The patients the investigators don't think suitable for this study.
Outcomes
Primary Outcomes
Rate of change of diagnosis
Time Frame: During 2 weeks
Finish diagnosis before and after getting the results of EUS-FNA
Secondary Outcomes
- Number of Participants with Adverse Events(5 years)